Therefore, changes in brain structure in healthy adults carrying APOE ε4 might be MRI biomarkers of pre-symptomatic AD that could identify potential participants for clinical trials of AD prevention or treatment before the onset of clinical symptoms, at which point interventions might be more effective [6]. Here, APOE is linked to Alzheimer disease.